Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals
To support the deployment of serology assays for population screening during the COVID-19 pandemic, we compared the performance of three fully automated SARS-CoV-2 IgG assays: Mindray CL-900i<sup>®</sup> (target: spike [S] and nucleocapsid [N]), BioMérieux VIDAS<sup>®</sup>3...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/9/2/245 |
id |
doaj-ca41e91601e3439099586db49bd8e661 |
---|---|
record_format |
Article |
spelling |
doaj-ca41e91601e3439099586db49bd8e6612021-01-26T00:05:28ZengMDPI AGMicroorganisms2076-26072021-01-01924524510.3390/microorganisms9020245Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 IndividualsSalma Younes0Hadeel Al-Jighefee1Farah Shurrab2Duaa W. Al-Sadeq3Nadin Younes4Soha R. Dargham5Nader Al-Dewik6Hamda Qotba7Mohamed Syed8Ahmed Alnuaimi9Hadi M. Yassine10Patrick Tang11Laith J. Abu-Raddad12Gheyath K. Nasrallah13Biomedical Research Center, Qatar University, Doha P.O. Box 2713, QatarBiomedical Research Center, Qatar University, Doha P.O. Box 2713, QatarBiomedical Research Center, Qatar University, Doha P.O. Box 2713, QatarBiomedical Research Center, Qatar University, Doha P.O. Box 2713, QatarBiomedical Research Center, Qatar University, Doha P.O. Box 2713, QatarInfectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation–Education City, Doha P.O. Box 24144, QatarClinical and Metabolic Genetics Section, Pediatrics Department, Hamad General Hospital (HGH), Hamad Medical Corporation, Doha P.O. Box 3050, QatarDepartment of Clinical Research, Primary Health Care Centers, Doha P.O. Box 26555, QatarDepartment of Clinical Research, Primary Health Care Centers, Doha P.O. Box 26555, QatarDepartment of Clinical Research, Primary Health Care Centers, Doha P.O. Box 26555, QatarBiomedical Research Center, Qatar University, Doha P.O. Box 2713, QatarDepartment of Pathology, Sidra Medicine, Doha P.O. Box 26999, QatarInfectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation–Education City, Doha P.O. Box 24144, QatarBiomedical Research Center, Qatar University, Doha P.O. Box 2713, QatarTo support the deployment of serology assays for population screening during the COVID-19 pandemic, we compared the performance of three fully automated SARS-CoV-2 IgG assays: Mindray CL-900i<sup>®</sup> (target: spike [S] and nucleocapsid [N]), BioMérieux VIDAS<sup>®</sup>3 (target: receptor-binding domain [RBD]) and Diasorin LIAISON<sup>®</sup>XL (target: S1 and S2 subunits). A total of 111 SARS-CoV-2 RT-PCR- positive samples collected at ≥ 21 days post symptom onset, and 127 pre-pandemic control samples were included. Diagnostic performance was assessed in correlation to RT-PCR and a surrogate virus-neutralizing test (sVNT). Moreover, cross-reactivity with other viral antibodies was investigated. Compared to RT-PCR, LIAISON<sup>®</sup>XL showed the highest overall specificity (100%), followed by VIDAS<sup>®</sup>3 (98.4%) and CL-900i<sup>®</sup> (95.3%). The highest sensitivity was demonstrated by CL-900i<sup>®</sup> (90.1%), followed by VIDAS<sup>®</sup>3 (88.3%) and LIAISON<sup>®</sup>XL (85.6%). The sensitivity of all assays was higher in symptomatic patients (91.1–98.2%) compared to asymptomatic patients (78.4–80.4%). In correlation to sVNT, all assays showed excellent sensitivities (92.2–96.1%). In addition, VIDAS<sup>®</sup>3 demonstrated the best correlation (r = 0.75) with the sVNT. The present study provides insights on the performance of three fully automated assays, which could help diagnostic laboratories in the choice of a particular assay according to the intended use.https://www.mdpi.com/2076-2607/9/2/245COVID-19SARS-CoV-2serologysensitivityspecificityneutralizing antibodies |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Salma Younes Hadeel Al-Jighefee Farah Shurrab Duaa W. Al-Sadeq Nadin Younes Soha R. Dargham Nader Al-Dewik Hamda Qotba Mohamed Syed Ahmed Alnuaimi Hadi M. Yassine Patrick Tang Laith J. Abu-Raddad Gheyath K. Nasrallah |
spellingShingle |
Salma Younes Hadeel Al-Jighefee Farah Shurrab Duaa W. Al-Sadeq Nadin Younes Soha R. Dargham Nader Al-Dewik Hamda Qotba Mohamed Syed Ahmed Alnuaimi Hadi M. Yassine Patrick Tang Laith J. Abu-Raddad Gheyath K. Nasrallah Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals Microorganisms COVID-19 SARS-CoV-2 serology sensitivity specificity neutralizing antibodies |
author_facet |
Salma Younes Hadeel Al-Jighefee Farah Shurrab Duaa W. Al-Sadeq Nadin Younes Soha R. Dargham Nader Al-Dewik Hamda Qotba Mohamed Syed Ahmed Alnuaimi Hadi M. Yassine Patrick Tang Laith J. Abu-Raddad Gheyath K. Nasrallah |
author_sort |
Salma Younes |
title |
Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals |
title_short |
Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals |
title_full |
Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals |
title_fullStr |
Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals |
title_full_unstemmed |
Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals |
title_sort |
diagnostic efficiency of three fully automated serology assays and their correlation with a novel surrogate virus neutralization test in symptomatic and asymptomatic sars-cov-2 individuals |
publisher |
MDPI AG |
series |
Microorganisms |
issn |
2076-2607 |
publishDate |
2021-01-01 |
description |
To support the deployment of serology assays for population screening during the COVID-19 pandemic, we compared the performance of three fully automated SARS-CoV-2 IgG assays: Mindray CL-900i<sup>®</sup> (target: spike [S] and nucleocapsid [N]), BioMérieux VIDAS<sup>®</sup>3 (target: receptor-binding domain [RBD]) and Diasorin LIAISON<sup>®</sup>XL (target: S1 and S2 subunits). A total of 111 SARS-CoV-2 RT-PCR- positive samples collected at ≥ 21 days post symptom onset, and 127 pre-pandemic control samples were included. Diagnostic performance was assessed in correlation to RT-PCR and a surrogate virus-neutralizing test (sVNT). Moreover, cross-reactivity with other viral antibodies was investigated. Compared to RT-PCR, LIAISON<sup>®</sup>XL showed the highest overall specificity (100%), followed by VIDAS<sup>®</sup>3 (98.4%) and CL-900i<sup>®</sup> (95.3%). The highest sensitivity was demonstrated by CL-900i<sup>®</sup> (90.1%), followed by VIDAS<sup>®</sup>3 (88.3%) and LIAISON<sup>®</sup>XL (85.6%). The sensitivity of all assays was higher in symptomatic patients (91.1–98.2%) compared to asymptomatic patients (78.4–80.4%). In correlation to sVNT, all assays showed excellent sensitivities (92.2–96.1%). In addition, VIDAS<sup>®</sup>3 demonstrated the best correlation (r = 0.75) with the sVNT. The present study provides insights on the performance of three fully automated assays, which could help diagnostic laboratories in the choice of a particular assay according to the intended use. |
topic |
COVID-19 SARS-CoV-2 serology sensitivity specificity neutralizing antibodies |
url |
https://www.mdpi.com/2076-2607/9/2/245 |
work_keys_str_mv |
AT salmayounes diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals AT hadeelaljighefee diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals AT farahshurrab diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals AT duaawalsadeq diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals AT nadinyounes diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals AT sohardargham diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals AT naderaldewik diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals AT hamdaqotba diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals AT mohamedsyed diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals AT ahmedalnuaimi diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals AT hadimyassine diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals AT patricktang diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals AT laithjaburaddad diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals AT gheyathknasrallah diagnosticefficiencyofthreefullyautomatedserologyassaysandtheircorrelationwithanovelsurrogatevirusneutralizationtestinsymptomaticandasymptomaticsarscov2individuals |
_version_ |
1724323633787043840 |